News articles tagged with "HIV"

03/27/2015 08:49:26
Douglas Smith
Finding an anti-AIDS vaccine remains an elusive goal—partly because the HIV virus quickly mutates to evade the vaccine's antibodies. In a Watson Lecture on April 1, Caltech's Pamela J. Bjorkman will describe ways to neutralize that mutational advantage.
06/30/2005 07:00:00
Jill Perry
The Grand Challenges in Global Health initiative, a major effort to achieve scientific breakthroughs against diseases that kill millions of people each year in the world's poorest countries, today offered 43 grants totaling $436.6 million for a broad range of innovative research projects involving scientists in 33 countries, including David Baltimore, president of the California Institute of Technology. The ultimate goal of the initiative is to create "deliverable technologies"--health tools that are not only effective, but also inexpensive to produce, easy to distribute, and simple to use in developing countries.
 
10/20/2004 07:00:00
Deborah Williams-Hedges
In response to the arduously slow progress in finding cures for AIDS and cancer, Caltech researchers are now investigating a promising new approach in the treatment of these diseases.
 
06/27/2003 07:00:00
Robert Tindol

With over 40 million people worldwide currently living with HIV/AIDS and millions more becoming infected each year, a group of scientists is callin

 
12/23/2002 08:00:00
Robert Tindol
New gene therapy that is highly effective in preventing the HIV virus.
 
01/10/2002 08:00:00
Using specially prepared HIV-derived viruses stripped of their disease-causing potential, California Institute of Technology biologist David Baltimore
 
04/28/1999 07:00:00
Robert Tindol

Caltech biologists have determined the three-dimensional structure of a protein that causes wasting in cancer and AIDS patients. The discovery could lead to new strategies for controlling weight loss in patients with devastating illnesses-and conversely, perhaps new strategies for fighting obesity.

Subscribe to Caltech News tagged with "HIV"